Benfotiamine
Single vitamin or mineral · 60 servings · $44.99 · 4.5 stars from 48 reviews
Worth trying for Cardiovascular health
May help: triglycerides. Tested in people who already had the problem
- Evidence Worth trying
- Dose 1 of 1 at a studied dose
- Safety Read the label's warnings
- Fillers None of concern
What's in it
The dose here lands inside the range studies actually used.
Supplement Facts
Serving Size: 2 Capsule(s)
60 per container
- Benfotiamine 300 mg †
† Daily Value not established
Other ingredients: Microcrystalline Cellulose, Hypromellose, Water, Ascorbyl Palmitate, Silica, Medium-Chain Triglyceride Oil.
Directions: Take two capsules in the morning and two capsules in the evening, or as directed by your healthcare professional.
Doses against the trials
-

Benfotiamine
At the studied dose
600 mg a day studies used 120–900 mg · 14 studies
What it's sold for
-
Cardiovascular health
Worth trying
-
Nerve function
Unproven
-
Thiamin status
Unproven
-
Energy support
Unproven
-
Healthy aging
Unproven
-
Nerve support
Not backed
-
Healthy blood sugar
Not backed
Worth knowing
The label's warnings
Consult your healthcare professional prior to use.
Individuals taking medication should discuss potential interactions with their healthcare professional.
Storage: Keep closed in a cool, dry place out of reach of children.
Reported side effects
Nausea
The other ingredients
Clean formula. The inactive ingredients are standard capsule components.
- Microcrystalline Cellulose: bulking agent
- Hypromellose: capsule shell material
- Water
- Ascorbyl Palmitate: antioxidant; benign
- Silica: flow agent; inert but filler
- Medium-Chain Triglyceride Oil
Free from
Vegetarian, Gluten Free, Dairy Free. Formulated to exclude: Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.
XYMOGEN
80 out of 100
Brand audit score
XYMOGEN shows a solid quality posture with NSF Certified for Sport listings and public company disclosures, but the available evidence remains limited.